Health Care: Drugs

Galena Biopharma Inc (GALE: NASDAQ)

$2.19 n/a | n/a%
09/19/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 2.49M 0.00 0.00 0.00
Cost of Sales 199.00K 0.00 0.00 0.00
Gross Operating Profit 2.29M 0.00 0.00 0.00
Selling, General, and Administrative Expenses 14.60M 6.58M 9.25M 8.75M
Research & Development 21.08M 14.61M 11.54M 7.87M
Operating Income before D & A (EBITDA) -33.39M -21.20M -20.79M -16.62M
Depreciation & Amortization 452.00K 49.00K 163.00K 172.00K
Interest Income 0.00 0.00 30.00K 5.00K
Other Income - Net -40.98M -13.14M 9.27M 4.63M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -74.82M -34.39M -11.65M -12.16M
Interest Expense 807.00K 33.00K 0.00 0.00
Pre-Tax Income -75.63M -34.43M -11.65M -12.16M
Income Taxes 1.05M -1.05M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -76.68M -33.32M -11.48M -11.99M
Net Income From Discontinued Operations 0.00 -1.64M 0.00 0.00
Net Income From Total Operations -76.68M -34.97M -11.48M -11.99M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -76.68M -34.97M -11.48M -11.99M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-76.68M -33.32M -11.48M -11.99M
Preferred Dividends
Net Income Available To Common -76.68M -33.32M -11.48M -11.99M
Basic EPS from Continuing Ops. -0.85 -0.53 -0.32 -0.67
Basic EPS from Discontinued Ops. 0.00 -0.03 0.00 0.00
Basic EPS from Total Operations -0.85 -0.56 -0.32 -0.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.85 -0.56 -0.32 -0.67
Basic Normalized Net Income/Share -0.85 -0.53 -0.32 -0.67
EPS fr Continuing Ops. -0.85 -0.53 -0.32 -0.67
EPS fr Discontinued Ops 0.00 -0.03 0.00 0.00
EPS fr Total Ops. -0.85 -0.56 -0.32 -0.67
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.85 -0.56 -0.32 -0.67
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.85 -0.53 -0.32 -0.67
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GALE

Latest GALE Headlines from TheStreet

More Financial News for GALE

Press Releases for GALE

See All Press Releases

Partner Headlines for GALE

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter